Top Markets
Coin of the day
Imagion Biosystems Limited Imagion Biosystems Limited

Imagion Biosystems Limited

IBX
Rang in Aktien #35262
Imagion Biosystems Limited operates as a medical imaging company that uses... Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry. The company has collaboration agreement with Wayne State University to develop optimised MRI sequences which is in Phase 2 study of for the MagSense imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.
Aktienkurs
$0.00775813
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$4.19M
Veränderung (1 Tag)
-15.38%
Veränderung (1 Jahr)
-20.49%
Land
AU
Handel Imagion Biosystems Limited (IBX)

Kategorie

Dividendenrendite-Verlauf für Imagion Biosystems Limited (IBX)
Dividendenrendite (TTM) von Imagion Biosystems Limited (Aktienkürzel: IBX) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Imagion Biosystems Limited (IBX) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber